Effects of intrathecally administered methysergide and yohimbine on microstimulation-produced antinociception in the rat

Nicholas Barbaro, Donna L. Hammond, Howard L. Fields

Research output: Contribution to journalArticle

99 Citations (Scopus)

Abstract

This study examined whether intrathecal (i.t.) administration of the serotonergic antagonist methysergide, of the α2 noradrenergic antagonist yohimbine, or of both drugs antagonized stimulation-produced antinociception (SPA) evoked from the nucleus raphe magnus (NRM) and the nucleus reticularis paragigantocellularis (NRPG) of lightly anesthetized rats. The increase in tail flick latency (TFL), but not the increase in paw pinch withdrawal threshold (PWT), evoked from NRM sites was antagonized by i.t. administration of methysergide. Intrathecal administration of yohimbine antagonized both the increase in TFL and the increase of PWT produced by stimulation of NRM sites. Stimulation of sites in the NRPG also increased TFL and PWT; these increases were not antagonized by i.t. administration of methysergide. Although i.t. administration of yohimbine antagonized the increase in TFL evoked from the NRPG, the increase in PWT was not antagonized. When coadministered intrathecally, methysergide and yohimbine antagonized the increases in TFL and PWT produced by stimulation of NRM and of NRPG sites. In contrast, i.v. administration of the same doses of methysergide and yohimbine did not antagonize either the increase in TFL or the increase in PWT evoked from either set of sites. These results support the concept that activation of serotonergic and noradrenergic bulbospinal neurons mediates SPA and additionally suggest that the noradrenergic component involves an α2 noradrenergic receptor.

Original languageEnglish (US)
Pages (from-to)223-229
Number of pages7
JournalBrain Research
Volume343
Issue number2
DOIs
StatePublished - Sep 23 1985
Externally publishedYes

Fingerprint

Methysergide
Yohimbine
Tail
Raphe Nuclei
Adrenergic Neurons
Nucleus Raphe Magnus
Pharmaceutical Preparations

Keywords

  • antinociception
  • intrathecal
  • methysergide
  • nucleus raphe magnus
  • nucleus reticularis paragigantocellalaris
  • spinal cord
  • stimulation-produced antinociception
  • yohimbine

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Effects of intrathecally administered methysergide and yohimbine on microstimulation-produced antinociception in the rat. / Barbaro, Nicholas; Hammond, Donna L.; Fields, Howard L.

In: Brain Research, Vol. 343, No. 2, 23.09.1985, p. 223-229.

Research output: Contribution to journalArticle

Barbaro, Nicholas ; Hammond, Donna L. ; Fields, Howard L. / Effects of intrathecally administered methysergide and yohimbine on microstimulation-produced antinociception in the rat. In: Brain Research. 1985 ; Vol. 343, No. 2. pp. 223-229.
@article{5c59ce6663fd45f2a522017f4e6cbcfa,
title = "Effects of intrathecally administered methysergide and yohimbine on microstimulation-produced antinociception in the rat",
abstract = "This study examined whether intrathecal (i.t.) administration of the serotonergic antagonist methysergide, of the α2 noradrenergic antagonist yohimbine, or of both drugs antagonized stimulation-produced antinociception (SPA) evoked from the nucleus raphe magnus (NRM) and the nucleus reticularis paragigantocellularis (NRPG) of lightly anesthetized rats. The increase in tail flick latency (TFL), but not the increase in paw pinch withdrawal threshold (PWT), evoked from NRM sites was antagonized by i.t. administration of methysergide. Intrathecal administration of yohimbine antagonized both the increase in TFL and the increase of PWT produced by stimulation of NRM sites. Stimulation of sites in the NRPG also increased TFL and PWT; these increases were not antagonized by i.t. administration of methysergide. Although i.t. administration of yohimbine antagonized the increase in TFL evoked from the NRPG, the increase in PWT was not antagonized. When coadministered intrathecally, methysergide and yohimbine antagonized the increases in TFL and PWT produced by stimulation of NRM and of NRPG sites. In contrast, i.v. administration of the same doses of methysergide and yohimbine did not antagonize either the increase in TFL or the increase in PWT evoked from either set of sites. These results support the concept that activation of serotonergic and noradrenergic bulbospinal neurons mediates SPA and additionally suggest that the noradrenergic component involves an α2 noradrenergic receptor.",
keywords = "antinociception, intrathecal, methysergide, nucleus raphe magnus, nucleus reticularis paragigantocellalaris, spinal cord, stimulation-produced antinociception, yohimbine",
author = "Nicholas Barbaro and Hammond, {Donna L.} and Fields, {Howard L.}",
year = "1985",
month = "9",
day = "23",
doi = "10.1016/0006-8993(85)90738-3",
language = "English (US)",
volume = "343",
pages = "223--229",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Effects of intrathecally administered methysergide and yohimbine on microstimulation-produced antinociception in the rat

AU - Barbaro, Nicholas

AU - Hammond, Donna L.

AU - Fields, Howard L.

PY - 1985/9/23

Y1 - 1985/9/23

N2 - This study examined whether intrathecal (i.t.) administration of the serotonergic antagonist methysergide, of the α2 noradrenergic antagonist yohimbine, or of both drugs antagonized stimulation-produced antinociception (SPA) evoked from the nucleus raphe magnus (NRM) and the nucleus reticularis paragigantocellularis (NRPG) of lightly anesthetized rats. The increase in tail flick latency (TFL), but not the increase in paw pinch withdrawal threshold (PWT), evoked from NRM sites was antagonized by i.t. administration of methysergide. Intrathecal administration of yohimbine antagonized both the increase in TFL and the increase of PWT produced by stimulation of NRM sites. Stimulation of sites in the NRPG also increased TFL and PWT; these increases were not antagonized by i.t. administration of methysergide. Although i.t. administration of yohimbine antagonized the increase in TFL evoked from the NRPG, the increase in PWT was not antagonized. When coadministered intrathecally, methysergide and yohimbine antagonized the increases in TFL and PWT produced by stimulation of NRM and of NRPG sites. In contrast, i.v. administration of the same doses of methysergide and yohimbine did not antagonize either the increase in TFL or the increase in PWT evoked from either set of sites. These results support the concept that activation of serotonergic and noradrenergic bulbospinal neurons mediates SPA and additionally suggest that the noradrenergic component involves an α2 noradrenergic receptor.

AB - This study examined whether intrathecal (i.t.) administration of the serotonergic antagonist methysergide, of the α2 noradrenergic antagonist yohimbine, or of both drugs antagonized stimulation-produced antinociception (SPA) evoked from the nucleus raphe magnus (NRM) and the nucleus reticularis paragigantocellularis (NRPG) of lightly anesthetized rats. The increase in tail flick latency (TFL), but not the increase in paw pinch withdrawal threshold (PWT), evoked from NRM sites was antagonized by i.t. administration of methysergide. Intrathecal administration of yohimbine antagonized both the increase in TFL and the increase of PWT produced by stimulation of NRM sites. Stimulation of sites in the NRPG also increased TFL and PWT; these increases were not antagonized by i.t. administration of methysergide. Although i.t. administration of yohimbine antagonized the increase in TFL evoked from the NRPG, the increase in PWT was not antagonized. When coadministered intrathecally, methysergide and yohimbine antagonized the increases in TFL and PWT produced by stimulation of NRM and of NRPG sites. In contrast, i.v. administration of the same doses of methysergide and yohimbine did not antagonize either the increase in TFL or the increase in PWT evoked from either set of sites. These results support the concept that activation of serotonergic and noradrenergic bulbospinal neurons mediates SPA and additionally suggest that the noradrenergic component involves an α2 noradrenergic receptor.

KW - antinociception

KW - intrathecal

KW - methysergide

KW - nucleus raphe magnus

KW - nucleus reticularis paragigantocellalaris

KW - spinal cord

KW - stimulation-produced antinociception

KW - yohimbine

UR - http://www.scopus.com/inward/record.url?scp=0022400651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022400651&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(85)90738-3

DO - 10.1016/0006-8993(85)90738-3

M3 - Article

C2 - 2996695

AN - SCOPUS:0022400651

VL - 343

SP - 223

EP - 229

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -